Fred Hutchinson Cancer Research Center bioengineer and cancer researcher Dr. Cyrus Ghajar has focused much of his work on what causes breast cancer cells to metastasize. Now, with the help of a new $1 million grant from the W.M. Keck Foundation, Ghajar and his team are hoping to crack open a mystery that has long puzzled scientists in the field: Why do metastatic cells, which can proliferate in many organs, nearly always fail to grow in skeletal muscles, which account for as much as half the body mass of an adult?
First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy; Fred Hutch hosts first-of-its-kind regional conference for science communicators; and Pathway that regulates organ size may also underlie tumors’ resistance to certain chemotherapy drugs.
A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
April 24, 2017
| By Sabrina Richards / Fred Hutch News Service
A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
March 31, 2017
| By Rachel Tompa / Fred Hutch News Service
Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.